SANA
Sana Biotechnology·NASDAQ
--
--(--)
--
--(--)
4.63 / 10
Netural
Money flow analysis registers 7.77/10, showing robust fund flow characteristics. Positive momentum in no significant trends is countered by negative tendencies in overall, block, Small, Medium, Large, and Extra-large, suggesting positive flow conditions. The analyst community expresses overwhelmingly bullish analyst consensus with strong conviction. Ratings composition: Strong Buy(33.3%), Buy(66.7%) representing 3 analyst views, supported by 1.50 historical weighted rating.
Fund Flow Rating
Analyst RatingBuy
Wall Street Opinions
Buy
Strong Buy
33%
Buy
67%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-11-07
InstitutionHC Wainwright & Co.
Times predicted3
Historical Win Rate33.3%
Is money flowing into or out of SANA?
- SANA holds a Bearish analyst rating, with 67% of experts assigning a Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 4.63/10 (Netural).
